U.S. market Closed. Opens in 10 hours 5 minutes

ESTA | Establishment Labs Holdings Inc. Stock Overview

(Stock Exchange: NASDAQ)
Day's Range 44.77 - 47.03
52 Week Range 16.96 - 60.12
Beta 0.95
Implied Volatility 95.89%
IV Rank 54.18%
Day's Volume 262,996
Average Volume 382,346
Shares Outstanding 27,943,531
Market Cap 1,306,639,510
Sector Healthcare
Industry Medical - Devices
IPO Date 2018-07-19
Valuation
Profitability
Growth
Health
P/E Ratio -14.89
Forward P/E Ratio N/A
EPS -3.14
1YR Price Target N/A
Dividend Yield N/A
Dividend Per Share N/A
Dividend ExDate N/A
Dividend PayDate N/A
Employees 857
Country Costa Rica
Website ESTA
Establishment Labs Holdings Inc., a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under Motiva Implants brand name. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander, as well as distributes Puregraft line of products for autologous adipose tissue harvesting and redistribution. The company sells its products through exclusive distributors and direct sales force in Europe, Latin America, the Asia-Pacific, and internationally. Establishment Labs Holdings Inc. was incorporated in 2004 and is headquartered in Alajuela, Costa Rica.
*Chart delayed
Analyzing fundamentals for ESTA we got that it has weak fundamentals where Valuation is considered to be significantly overvalued, Profitability is unacceptably poor, Growth is desperately bad and Health is very weak. For more detailed analysis please see ESTA Fundamentals page.

Watching at ESTA technicals we can see that long-term trend is bullish, the same as bullish middle-term trend, as well as bullish short-term trend. More technicals details can be found on ESTA Technicals page.
An error has occurred. This application may no longer respond until reloaded. Reload 🗙